Volume : 09, Issue : 10, October – 2022

Title:

92.THE MOST IMPORTANT VISION EXAMINATION AND ITS RELATIONSHIP TO RETINOPATHY IN DIABETIC PATIENTS

Authors :

Naif.Z.Alsulami , Ibrahim.A.Bakkari, Mousa.R.Alessa, Wael.M.Alsayed, Mohammed.A.Hazazi, Khalid.S.Alhazmi, Rabee.O.Algothami,Nabeel.A.Al Sharahili

Abstract :

The aim of the study is the importance of examining eyesight for diabetics to prevent retinopathy, the importance of exercising regularly to prevent diabetes, the importance of performing regular eye examinations for diabetics, the importance of not driving a car immediately after an eye examination due to side effects, the importance of checking lipids and blood sugar levels regularly to avoid Having diabetes, the importance of quitting the bad smoking habit. A questionnaire was created and designed via Google Drive and distributed on the social media network (WhatsApp) to health practitioners and practices in Mecca. 800 questionnaires were distributed and responses were obtained to 750 questionnaires from the targeted targets (health practitioners).
Keywords: Important, Eye examination, Diabetic.

Cite This Article:

References:

1-Change the Definition of Blindness” (PDF). World Health Organization. Archived (PDF) from the original on 14-07-2015. Viewed on 23-5-2015
2- Blindness and Vision Impairment”. February 8, 2011. Archived from the original on April 29, 2015. Viewed on 23-05-2015
3- Maberley, D. A.; Hollands, H; Chuo, J; Tam, G; Konkal, J; Roesch, M; Veselinovic, A; Witzigmann, M; Bassett, K (March 2006). “The prevalence of low vision and blindness in Canada”. Eye (London, England). C. 20 p. 3: 341–6. DOI:10.1038/sj.eye.6701879. PMID:15905873.
4- Visual impairment and blindness Fact Sheet N°282″. August 2014. Archived from the original on 12-05-2015. Accessed on 23-05-2015
5-.GLOBAL DATA ON VISUAL IMPAIRMENTS 2010 (PDF). WHO. 2012. p. 6. Archived (PDF) from the original on 31-03-2015.
6- Lehman, S.S. (September 2012). “Cortical visual impairment in children: identification, evaluation and diagnosis”. Current Opinion in Ophthalmology. C. 23 p. 5: 384–7. DOI:10.1097/ICU.0b013e3283566b4b. PMID:22805225.
7-Expert Committee on the Diagnosis Classification of Diabetes Mellitus (January 2003). “Report of the expert committee on the diagnosis and classification of diabetes mellitus”. Diabetes Care. C. 26 p. Suppl 1: S5–20. DOI:10.2337/diacare.26.2007.S5. PMID:12502614.
8-Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A (October 2004). “Epidemiology of diabetic retinopathy and macular oedema: a systematic review”. Eye. C. 18 p. 10:963–83. DOI:10.1038/sj.eye.6701476. PMID:15232600.
9-Ryeom S, Folkman J (March 2009). “Role of endogenous angiogenesis inhibitors in Down syndrome”. The Journal of Craniofacial Surgery. 20 Suppl 1 p. Suppl 1:595–6. DOI:10.1097/SCS.0b013e3181927f47. PMID:19795527. S2CID:21576950.
10-Porta M, Bandello F: Diabetic retinopathyA clinical update. Diabetologia 2002, 45(12):1617-1634
11-Bamashmus MA, Matlhaga B, Dutton GN: Causes of blindness and
visual impairment in the West of Scotland. Eye 2004,
18(3):257-261
12-Hapnes R, Bergrem H: Diabetic eye complications in a medium sized municipality in southwest Norway. Acta Ophthalmol Scand 1996, 74(5):497-500.
13-Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF: A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent)diabetic patients. Diabetologia 1992, 35(11):1049-1054.
14-Stene LC, Midthjell K, Jenum AK, Skeie S, Birkeland KI, Lund E, Joner G, Tell GS, Schirmer H: [Prevalence of diabetes mellitus in Norway.]. Tidsskr Nor Laegeforen 2004, 124(11):1511-1514.
15-Younis N, Broadbent DM, Harding SP, Vora JR: Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet Med 2002,19(12):1014-1021
16-Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR,Manley SE, Matthews DR: UKPDS 50: risk factors for incidenceand progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001, 44(2):156-163.
17-Bunce C, Wormald R: Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006, 6:58
18-Rohrschneider K, Greim S: [Epidemiology of blindness in Baden, Germany]. Klin Monatsbl Augenheilkd 2004, 221(2):116-121.
19-Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 1998,21(1):143-156
20-Zoega GM, Gunnarsdottir T, Bjornsdottir S, Hreietharsson AB, Viggosson G, Stefansson E: Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 2005, 83(6):687-690.
21-Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E: Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 2000, 78(4):374-385.
22-Javitt JC, Aiello LP: Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 1996, 124(1 Pt 2):164-169. 23- Claudi T, Cooper JG, Midthjell K, Daae C, Furuseth K, Hanssen KF: [NSAMs guidelines for diabetes in general practice 2005. Short version]. Norsk selskap for allmennmedisin, Den norske Lægeforening, Norges Diabetesforbund; 2005.
24-Alserahy, Hassan Awad, et al (2008), The thinking and scientific research, Scientific Publishing Center, King Abdul-Aziz University in Jeddah, the first edition
25-Al Zoghbi, Muhammad and AlTalvah, Abas (2000), Statistical system understanding and analysis of statistical data, first edition, Jordon- Amman
26-. Kadasah, N.A.; Chirwa, G.C.; et al. Knowledge, Attitude, and Practice Toward COVID-19 Among the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study. Front. Public Health 2020, 8, 217.